The impact of PET-FES on changing therapeutic conduct in bilateral luminal phenotype breast cancer
Mastology · 07.04.2026 · 35
DOI: 10.29289/259453942025055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mastology, online erschienen am 07.04.2026. Verfasst von Maria Marta Martins und 5 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Positron emission tomography with ¹⁸F-fluoroestradiol (PET-FES) is a functional imaging exam that assesses the expression of estrogen receptors and is highly sensitive in detecting metastases in luminal tumors, which represent the majority of breast cancer cases. We report the case of a 75-year-old patient with bilateral breast carcinoma, whose initial treatment would be adjuvant chemotherapy based on positron emission tomography/computed tomography (PET-CT) with fluorodeoxyglucose (FDG), which showed no evidence of metastases. However, PET-FES identified metastatic involvement in lymph nodes and the skeleton, reclassifying the disease to stage IV. This new assessment made it possible to replace chemotherapy with endocrine therapy associated with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, a more effective and less toxic approach for the metastatic scenario. The unavailability of PET-FES in the public system and in several private health insurance plans constitutes an ethical imperative, as it limits access to precision diagnostics. This reality highlights structural inequalities in Brazilian oncology, representing a dilemma that requires public policies and evidence-based solutions to ensure equity in cancer treatment.
Zitieren
APA
Martins, M. M., Lucarelli, A. P., Vasconcelos, G. M., Divino, P. H. D. A., Szechtman, G. D., & Rea, M. S. (2026). The impact of PET-FES on changing therapeutic conduct in bilateral luminal phenotype breast cancer. Mastology, 35. https://doi.org/10.29289/259453942025055
Vancouver
Martins MM, Lucarelli AP, Vasconcelos GM, Divino PHDA, Szechtman GD, Rea MS. The impact of PET-FES on changing therapeutic conduct in bilateral luminal phenotype breast cancer. Mastology. 2026;35. doi:10.29289/259453942025055
BibTeX
@article{Martins2026,
author = {Martins, Maria Marta and Lucarelli, Adrienne Pratti and Vasconcelos, Gabriela Martins and Divino, Paulo Henrique do Amor and Szechtman, Giulia Dematte and Rea, Maria Silveira},
title = {The impact of PET-FES on changing therapeutic conduct in bilateral luminal phenotype breast cancer},
journal = {Mastology},
year = {2026},
volume = {35},
doi = {10.29289/259453942025055}
}
EUVIMED